Perimeter Medical Imaging to Exhibit at Fall Breast Cancer Summit
Perimeter Medical Imaging Showcases Innovations at Key Symposium
At a pivotal gathering of breast cancer professionals, Perimeter Medical Imaging AI demonstrated its cutting-edge imaging technology designed for breast cancer care. This event, known as the "Take the Lead in Breast Cancer Care" summit, is known for bringing together top physicians and specialists in the field to foster discussions around improving patient outcomes.
Groundbreaking Technology for Enhanced Patient Outcomes
Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) is focused on transforming cancer surgery with its innovative S-Series OCT (Optical Coherence Tomography) technology. This pioneering device allows surgeons to visualize excised tissues in real-time, bringing a new level of precision during critical procedures.
Key Benefits of the OCT Technology
As healthcare continues to advance, developments in surgical technology are crucial. Perimeter's OCT technology enables real-time, high-resolution imaging, helping surgeons assess the tissue margins more accurately. This capability is essential in ensuring the complete removal of cancerous cells during surgery, thereby reducing the chances of re-excision for patients.
Involvement in the Summit
During the summit, which gathered esteemed professionals from various disciplines including surgery, oncology, and pathology, Perimeter's CEO, Adrian Mendes, highlighted the opportunity to present their advancements to leading experts in breast cancer care. He expressed the significance of the forum in fostering collaborative strategies to advance treatment options.
The Future of Intraoperative Care
Mendes shared insights on how integrating artificial intelligence with their imaging technology could signify a major leap forward in intraoperative care. With enhanced visualization, surgical teams can make better-informed decisions during operations, ultimately benefiting patient care.
Achievements and Future Endeavors
Perimeter's S-Series OCT gained FDA clearance in 2021, marking a significant milestone for the company. Currently, the FDA is evaluating an AI-assisted version of this technology, aimed specifically at enhancing intraoperative imaging for breast cancer surgeries. This evaluation is crucial as it underscores Perimeter's commitment to innovation and excellence in medical technology.
Expanding Reach and Resources
The company’s next-generation imaging technology is actively being utilized across the United States. Alongside their existing products, the FDA-designated breakthrough device, Perimeter B-Series OCT, is undergoing pivotal trials with support from a generous grant of up to $7.4 million from a prominent cancer research institute.
Closing Thoughts
Perimeter Medical Imaging is dedicated to not only providing state-of-the-art imaging solutions but also ensuring that these technologies lead to better health outcomes for patients. Their participation in significant medical forums reflects their commitment to advancing breast cancer care and fostering collaborations that can shape the future of oncology.
Frequently Asked Questions
What is the primary focus of Perimeter Medical Imaging AI?
Perimeter is dedicated to transforming cancer surgery through advanced imaging technologies, particularly for breast cancer treatment.
When and where did Perimeter showcase its technology recently?
Perimeter showcased its technology at the "Take the Lead in Breast Cancer Care" summit.
How does Perimeter's imaging technology work?
The imaging technology uses optical coherence tomography (OCT) to provide real-time visualization of excised tissues, enhancing surgical precision.
What recent achievement has the S-Series OCT reached?
The S-Series OCT received FDA clearance in 2021, allowing its use in medical practices across the U.S.
How is artificial intelligence being integrated into Perimeter's technology?
Perimeter is developing an AI-assisted version of their imaging technology to further enhance diagnostic accuracy during surgeries.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.